GoodRx Holdings Inc (GDRX) concluded trading on Wednesday at a closing price of $3.79, with 8.88 million shares of worth about $33.66 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -38.77% during that period and on May 07, 2025 the price saw a loss of about -11.03%. Currently the company’s common shares owned by public are about 105.95M shares, out of which, 88.88M shares are available for trading.
Stock saw a price change of -18.14% in past 5 days and over the past one month there was a price change of -5.49%. Year-to-date (YTD), GDRX shares are showing a performance of -18.49% which decreased to -46.62% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.82 but also hit the highest price of $9.26 during that period. The average intraday trading volume for GoodRx Holdings Inc shares is 1.48 million. The stock is currently trading -16.00% below its 20-day simple moving average (SMA20), while that difference is down -16.58% for SMA50 and it goes to -33.44% lower than SMA200.
GoodRx Holdings Inc (NASDAQ: GDRX) currently have 105.95M outstanding shares and institutions hold larger chunk of about 16.10% of that.
The stock has a current market capitalization of $1.44B and its 3Y-monthly beta is at 1.25. PE ratio of stock for trailing 12 months is 88.97, while it has posted earnings per share of $0.04 in the same period. Its PEG reads 5.59 and has Quick Ratio of 5.32 while making debt-to-equity ratio of 0.75. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GDRX, volatility over the week remained 8.67% while standing at 5.94% over the month.
Stock’s fiscal year EPS is expected to rise by 14.92% while it is estimated to increase by 21.29% in next year. EPS is likely to grow at an annualized rate of 15.91% for next 5-years, compared to annual growth of -17.73% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Mizuho on December 04, 2024 offering a Neutral rating for the stock and assigned a target price of $5 to it. Coverage by Raymond James stated GoodRx Holdings Inc (GDRX) stock as a Strong buy in their note to investors on August 09, 2024, suggesting a price target of $10 for the stock. On May 23, 2024, RBC Capital Mkts Upgrade their recommendations, while on May 16, 2024, Raymond James Upgrade their ratings for the stock with a price target of $10. Stock get an Overweight rating from KeyBanc Capital Markets on April 10, 2024.
